Fat grafting is evolving—faster, cleaner, and more effective than ever before. Could a new fat-processing device reshape the future of regenerative beauty?

In this episode, Dr. Grant Stevens interviews Ahmed Zobi, CEO of Syntr Health Technologies, about a revolutionary advancement in autologous fat processing. Born from a university research project and fueled by personal motivation, Syntr’s rotor-based microfluidic system is the first FDA-cleared device of its kind to be used in a human clinical trial for facial fat grafting.

Ahmed explains how this cutting-edge, closed-system platform delivers highly viable fat cells for safer, cleaner, and more consistent outcomes—ideal for mid-face augmentation, breast reconstruction, and even orthopedic support. They dive into Syntr’s journey from NIH grants to commercialization, how the device is enabling next-generation PRP and exosome research, and why automation and reproducibility are critical for the future of regenerative medicine.

Whether you're a clinician, innovator, or investor, tune in to the latest episode of The Technology of Beauty for insights into the evolving landscape of biotechnological aesthetics.

» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426
» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm
» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/
» Instagram | https://www.instagram.com/thetechnologyofbeauty/
» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/

The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/

Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level. https://www.influxmarketing.com/next-level-practices/